Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Change in Accured Expenses (2016 - 2025)

Alkermes (ALKS) has disclosed Change in Accured Expenses for 16 consecutive years, with $100.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 300.65% to $100.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $100.9 million, a 274.05% increase, with the full-year FY2025 number at $100.9 million, up 274.05% from a year prior.
  • Change in Accured Expenses was $100.2 million for Q4 2025 at Alkermes, up from -$55.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $100.2 million in Q4 2025 to a low of -$81.0 million in Q3 2024.
  • A 5-year average of $3.7 million and a median of $6.1 million in 2022 define the central range for Change in Accured Expenses.
  • Biggest YoY gain for Change in Accured Expenses was 1119.45% in 2024; the steepest drop was 8516.2% in 2024.
  • Alkermes' Change in Accured Expenses stood at -$19.9 million in 2021, then skyrocketed by 131.89% to $6.3 million in 2022, then crashed by 67.65% to $2.1 million in 2023, then skyrocketed by 1119.45% to $25.0 million in 2024, then surged by 300.65% to $100.2 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Change in Accured Expenses are $100.2 million (Q4 2025), -$55.4 million (Q3 2025), and $53.3 million (Q2 2025).